IP Verse

Baxalta Incorporated competitive analysis

Latest publications and patents of Baxalta Incorporated New

Explore the latest publications and patents granted to Baxalta Incorporated, showcasing their recent innovations and technological advancements.

Last updated on: Sep 27, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Baxalta Incorporated

EP3064508
Mar 15, 2023Method Of Producing Recombinant High Molecular Weight Vwf In Cell CulturePatent Maintained As Amended
EP3521422
Oct 6, 2021Substantially Animal Protein-Free Recombinat Furin And Methods For Producing SameGranted And Under Opposition
EP3277718
Mar 24, 2021Dosage Regimen For Anti-Mif AntibodiesRevoked
EP3121266
Apr 22, 2020Oligopeptide-Free Cell Culture MediaRevoked
EP2739641
Apr 15, 2020Systems And Methods To Increase Protein Yield From Recombinant Manufacturing ProcessesPatent Maintained As Amended
EP3116534
May 29, 2019Compositions Of Human Prothrombin And Activated Factor X For Improving Hemostasis In The Treatment Of Bleeding DisordersRevoked
EP2753937
Jan 17, 2018Characterization Of Cho-Mif Gene And Protein, And Use ThereofNo Opposition Filed Within Time Limit
EP2652491
Nov 29, 2017Eluate Collection Using Conductivity GradientOpposition Rejected
EP2295547
Sep 20, 2017Recombinant Co-Expression Of Vitamin K Epoxide Reductase Subunit 1 To Improve Vitamin K Dependant Protein ExpressionRevoked
EP1974014
Apr 19, 2017Oligopeptide-Free Cell Culture MediaRevoked

Latest patents of Baxalta Incorporated opposed by its competitors

Explore Baxalta Incorporated's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3064508
Mar 15, 2023Method Of Producing Recombinant High Molecular Weight Vwf In Cell Culture1
EP3521422
Oct 6, 2021Substantially Animal Protein-Free Recombinat Furin And Methods For Producing Same1
EP3277718
Mar 24, 2021Dosage Regimen For Anti-Mif Antibodies1
EP3121266
Apr 22, 2020Oligopeptide-Free Cell Culture Media6
EP2739641
Apr 15, 2020Systems And Methods To Increase Protein Yield From Recombinant Manufacturing Processes1
EP3116534
May 29, 2019Compositions Of Human Prothrombin And Activated Factor X For Improving Hemostasis In The Treatment Of Bleeding Disorders1
EP2652491
Nov 29, 2017Eluate Collection Using Conductivity Gradient1
EP2295547
Sep 20, 2017Recombinant Co-Expression Of Vitamin K Epoxide Reductase Subunit 1 To Improve Vitamin K Dependant Protein Expression1
EP1974014
Apr 19, 2017Oligopeptide-Free Cell Culture Media6

Latest PTAB cases involving Baxalta Incorporated

Discover the latest PTAB cases involving Baxalta Incorporated, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Baxalta Incorporated with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
BAXALTA INCORPORATED - 19 - - Non-Active
APTEVO BIOTHERAPEUTICS1 - - - Highly Aggressive
BREUER16 - - - Highly Aggressive
STRAWMAN331 - - - Highly Aggressive